K
Kaiser Permanente | Division of Research
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
VX-121
VX-445
CTP-543
Icosapent Ethyl
pegcrisantaspase
BMS-986036
Aztreonam
Nucleos(t)Ide
Olaparib
Lenacapavir
Parent organization
This site is a part of Kaiser Permanente
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 23 total trials
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in pa...
Active, not recruiting
Cystic Fibrosis
Drug: VX-121/TEZ/D-IVA
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy.
Active, not recruiting
FIGO Stage III-IV
Newly Diagnosed
Drug: Olaparib 300mg tablets
The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.
Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: PTM F/TDF
Drug: Placebo SC LEN
Trial sponsors
S
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems